1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE:TGIF, OTCQX:TGIFF), a vertically-integrated and growth-orientated cannabis consumer packaged goods company, is pleased to announce a licensing agreement (the ‘Agreement’) between the Company’s subsidiary, Alternative Medicine Association LLC (“AMA”) and Capna Intellectual, Inc., developer of The Bloom Brand (“Bloom™”). The one-year agreement was executed in December and received state approval in January, and awards AMA the exclusive license to manufacture a wide range of Bloom™ products for the Nevada market.

1933 industries bloom brand


Established in California in 2014, Bloom™ is now sold in over three hundred licensed retailers in California, Nevada, Washington and New Mexico, with further expansion planned for new markets in Oklahoma, Massachusetts and Canada.

In 2015, AMA was the first licensed cultivator in Southern Nevada. Today, AMA continues its tradition of cultivating craft cannabis in a newly-constructed, state-of-the-art, purpose-built facility in Las Vegas, offering consistency and scalability. Well-known for its premium quality cannabis products, AMA produces a variety of THC concentrates, as well as oils used in vape pen cartridges, with a variety of terpene profiles for flavours and aromas.

“Our companies focus on end-use cannabis products that provide the highest quality ingredients and that are safe for consumers”, remarked Ms. Ester Vigil, President of 1933 Industries. “Our goal is to expand beyond our proprietary AMA products and represent the very best cannabis brands in Nevada, offering a full suite of differentiated product lines. Bloom™ is a brand we have been watching for some time, waiting for the opportune time to work together. We are impressed by the professionalism of the Bloom™ team and we are proud to represent such a highly rewarded brand in Nevada”, Ms. Vigil continued.

Providing an experience that is as close to the cannabis plant as possible and delivered in a tasteful and convenient way, the Bloom™ licensed products include:

  • Bloom™ Vape – Original vapor method available in a 500mg cartridge
  • Bloom™ One – Disposable vapor method providing the same flavorful experience in a smaller, 350mg preloaded, disposable package
  • Bloom™ Dart – Pod vapor method includes CCELL’s advanced ceramic heating elements for greater oil absorption
  • Bloom™ Drop – Oil infusion method comes with 800mg of oil with pre-activated THC. The oil can be added to flower, dabs or for infusing food for instant effects
  • Bloom™ Kit – Pocket-sized vape battery for Bloom cartridges, featuring a sleek buttonless design, which activates as one inhales

Bloom™ products do not contain any additives, PG, VG, or vitamin E Acetate.

“Consistency is at the core of everything we do, so it was integral for us to find the right partners to act as an extension of our vision,” said CEO and co-founder of Bloom™, Mr. Vitaly Mekk, “We are thrilled to begin this partnership with 1933. Their extensive cannabis history and experience in Nevada give us confidence that we will be able to achieve our goals together.”

About Capna Intellectual
Pulling from a diverse background in cannabis retail, CPG, and technology, Capna Intellectual’s mission is to develop authentic products that deliver unforgettable cannabis experiences. Capna Intellectual is known for developing Bloom, a pioneering cannabis brand that was established in Southern California in 2014. Bloom is now sold in over three hundred retailers across four States: California, Nevada, Washington and New Mexico. In 2020, Capna Intellectual will continue the rapid growth of the brand by adding additional product categories while launching in three new markets: Oklahoma, Canada and Massachusetts.

About 1933 Industries Inc.
1933 Industries is a vertically-integrated, growth-orientated company, focusing on the cultivation and manufacturing of cannabis consumer branded goods in a wide range of product formats. Operating through two subsidiaries, the Company controls all aspects of the value chain with cultivation, extraction, processing, and manufacturing assets supporting its diversified portfolio of cannabis brands and licensing partners.

Our award-winning proprietary portfolio of brands include: AMA flower and AMA concentrates as well as CBD-infused Canna Hemp™, Canna Hemp X™, and Canna Fused™ products. Partners under licensing agreements include: Birdhouse Skateboards™, Blonde™ Cannabis, Bloom™, Denver Dab Co., Grizzly Griptape, OG DNA Genetics, The Pantry Company, PLUGplay, and The Original Jack Herer®.

The Company owns 91% of Alternative Medicine Association, LC (AMA), and 100% of Infused MFG LLC. 1933 Industries continues to focus its operations in the licensed US cannabis industry as a multi-state operator in Nevada, Colorado and California.

About Canna Hemp™
Canna Hemp™ CBD Relief Cream was named “Best Topical” by Leafy’s Best in State: The Top State Specific Products and Experiences of 2018.
http://www.cannahemp.com
https://www.leafly.com/news/strains-products/best-in-state-2018-nevada-cannabis

About Canna HempX™
Canna Hemp X™ was named “Best Topicals for Pain” by Herb’s Guide to the Best Cannabis Products on the Planet. Canna Hemp X™ is a CBD sports recovery cream for athletes, bridging the gap between recovery and top performance.
http://www.cannahempx.com
https://herb.co/learn/best-cannabis-products/

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct.  Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com.   1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Click here to connect with 1933 Industries Inc. (CSE:TGIF, FWB:1QF, OTC:VPGDF) for an Investor Presentation.

Source

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less